Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same

Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same

US Patent 9700575 · Granted Jul 11, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Clevidipine nanoparticles and pharmaceutical compositions thereof2025
Use of exosome derived from decidual natural killer (dNK) cells or dNK cell subs2025
Substituted bicyclic compounds useful as T cell activators2024
Naphthyridinone compounds useful as T cell activators2024
Clevidipine nanoparticles and pharmaceutical compositions thereof2023
Substituted naphthyridinone compounds useful as T cell activators2023
Clevidipine emulsion formulations containing antimicrobial agents2021
Pharmaceutical compositions and methods for producing low impurity concentration2021
Pharmaceutical compositions and methods for producing low impurity concentration2021
Substituted naphthyridinone compounds useful as T cell activators2021
High purity oritavancin and method of producing same2020
High purity oritavancin and method of producing same2020